Page last updated: 2024-08-26

cytidylyl-3',5'-adenosine and Heart Disease, Ischemic

cytidylyl-3',5'-adenosine has been researched along with Heart Disease, Ischemic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Carr, CS; Hill, RJ; Kennedy, SP; Knight, DR; Masamune, H; Tracey, WR; Yellon, DM	1

Other Studies

1 other study(ies) available for cytidylyl-3',5'-adenosine and Heart Disease, Ischemic

Article	Year
Evidence for a role for both the adenosine A1 and A3 receptors in protection of isolated human atrial muscle against simulated ischaemia. Cardiovascular research, 1997, Volume: 36, Issue:1 Topics: Adenosine; Dinucleoside Phosphates; Heart Atria; Humans; In Vitro Techniques; Ischemic Preconditioning, Myocardial; Models, Biological; Myocardial Contraction; Myocardial Ischemia; Myocardial Reperfusion; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptor, Adenosine A3; Receptors, Purinergic P1; Xanthines	1997

Article

Year

Evidence for a role for both the adenosine A1 and A3 receptors in protection of isolated human atrial muscle against simulated ischaemia.

Cardiovascular research, 1997, Volume: 36, Issue:1

Topics: Adenosine; Dinucleoside Phosphates; Heart Atria; Humans; In Vitro Techniques; Ischemic Preconditioning, Myocardial; Models, Biological; Myocardial Contraction; Myocardial Ischemia; Myocardial Reperfusion; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptor, Adenosine A3; Receptors, Purinergic P1; Xanthines

1997